Dan Landau, MD, PhD, is physician-scientist who integrates data science innovation with genomic technology development to unravel the basic principles of tumor evolution as a key to cancer cure.
He gained his MD from Tel Aviv University and summa cum laude PhD in Cancer Biology from Paris Diderot University. He completed a Medicine residency and fellowship in Hematology and Medical Oncology at Yale University, as well as postdoctoral fellowship at Dana Farber Cancer Institute and the Broad Institute of Harvard and MIT. He now serves as an Assistant Prof. of Medicine at the Meyer Cancer Center (WCM), and member of the WCM Institute of Computational Biomedicine, as well as a Core Member of the NYGC.
His studies defined cancer genetic and epigenetic diversity and its contribution to cancer evolution. His work received numerous awards including the Burroughs Wellcome Fund Career Award for Medical Scientists, K01 from the Big Data to Knowledge (BD2K) NIH initiative, SU2C Innovative Research Grant, and the NIH Director’s New Innovator Award.